Company intelligence / Profile preview

Smileyscope

Austin, Texas, United Statessmileyscope.com.au ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

Smileyscope’s VR system has demonstrated significant reductions in pain (~60%) and anxiety (~40%) during pediatric needle procedures in randomized controlled trials. The device has been FDA-cleared as a Class II Medical Device for acute pain and procedural anxiety reduction. Over 100,000 procedures have been performed globally using the technology.

Therapeutic areas: OtherPsychiatry
Modalities: DeviceNon-pharmacological therapyDigital therapeutic (virtual reality neuromodulation)
Industry: Therapeutic Medical Devices

Partnerships

Over 50 US hospitals implementing the technology

Beyond the preview

Go deeper on Smileyscope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smileyscope.

Explore the full profile